| 69097-641-03 |
69097-641 |
HUMAN PRESCRIPTION DRUG |
Nintedanib |
Nintedanib |
CAPSULE |
ORAL |
20260402 |
N/A |
ANDA |
ANDA212609 |
Cipla USA Inc. |
NINTEDANIB ESYLATE |
100 mg/1 |
60 CAPSULE in 1 BOTTLE (69097-641-03) |
| 76282-786-60 |
76282-786 |
HUMAN PRESCRIPTION DRUG |
Nintedanib Capsules, 100 mg and 150 mg |
Nintedanib |
CAPSULE |
ORAL |
20260507 |
N/A |
ANDA |
ANDA212609 |
EXELAN PHARMACEUTICALS INC. |
NINTEDANIB ESYLATE |
100 mg/1 |
60 CAPSULE in 1 BOTTLE (76282-786-60) |
| 76282-787-60 |
76282-787 |
HUMAN PRESCRIPTION DRUG |
Nintedanib Capsules, 100 mg and 150 mg |
Nintedanib |
CAPSULE |
ORAL |
20260507 |
N/A |
ANDA |
ANDA212609 |
EXELAN PHARMACEUTICALS INC. |
NINTEDANIB ESYLATE |
150 mg/1 |
60 CAPSULE in 1 BOTTLE (76282-787-60) |
| 69097-639-03 |
69097-639 |
HUMAN PRESCRIPTION DRUG |
Nintedanib |
Nintedanib |
CAPSULE |
ORAL |
20260402 |
N/A |
ANDA |
ANDA212609 |
Cipla USA Inc. |
NINTEDANIB ESYLATE |
150 mg/1 |
60 CAPSULE in 1 BOTTLE (69097-639-03) |